Clinical Trial Update: Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating weekly topotecan in patients with metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Colon Cancer | Phase 2 | Status: COMPLETED